OmniAb, Inc. (OABI)
4.59
-0.14
(-2.96%)
USD |
NASDAQ |
Oct 16, 16:00
4.585
0.00 (0.00%)
After-Hours: 20:00
OmniAb SG&A Expense (TTM) : 26.89M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.89M |
| March 31, 2026 | 27.92M |
| December 31, 2025 | 29.22M |
| September 30, 2025 | 29.74M |
| June 30, 2025 | 30.04M |
| March 31, 2025 | 30.32M |
| December 31, 2024 | 30.74M |
| September 30, 2024 | 31.25M |
| June 30, 2024 | 32.68M |
| March 31, 2024 | 33.46M |
| December 31, 2023 | 33.31M |
| Date | Value |
|---|---|
| September 30, 2023 | 35.65M |
| June 30, 2023 | 32.72M |
| March 31, 2023 | 28.99M |
| December 31, 2022 | 24.90M |
| September 30, 2022 | 19.04M |
| June 30, 2022 | 13.63M |
| March 31, 2022 | 8.629M |
| December 31, 2021 | 4.525M |
| September 30, 2021 | 0.1806M |
| June 30, 2021 | 0.01M |
| March 31, 2021 | 0.0078M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| IQVIA Holdings, Inc. | 2.058B |
| Champions Oncology, Inc. | 21.81M |
| Medpace Holdings, Inc. | 189.02M |
| Charles River Laboratories International, Inc. | 762.04M |
| Avantor, Inc. | 1.599B |